At Sky Foundation, Inc., we believe in the power of community to drive awareness, fund research, and support those impacted by pancreatic cancer. Our fundraising events bring people together to make a difference—while having a great time!
Volunteer, sponsor, or start a fundraiser—every action makes a lasting impact in the fight against pancreatic cancer. Your involvement fuels life-saving research, raises critical awareness, and supports patients, survivors, and families. Together, we can drive progress and bring hope to every life touched by this disease.
Brought to you by Sky Foundation, Inc. and TriCan Health, this free educational webinar series helps patients and families better understand pancreatic cancer clinical trials and how they fit into care decisions. Each session breaks down complex topics into clear, patient-friendly language—focusing on education, transparency, and empowerment.
Sky Foundation funds innovative research focused on the early detection and treatment of pancreatic cancer. Through our seed grants, we help researchers launch groundbreaking ideas that can lead to major advances and long-term impact. Every dollar raised moves us closer to detecting pancreatic cancer sooner and saving more lives.
From caregiver resources to survivor stories, Sky Foundation connects patients, families, and supporters with the guidance they need. Our community of survivors and advocates—each touched by pancreatic cancer—offers understanding, strength, and hope to help others navigate their own journey.
Learn more about Sky Foundation
Sky's Funded Research Team
Slide 3
Adrianne Wallace-Povirk, PhD
Henry Ford Health, Pancreatic Cancer Center
Slide 6
Harrison L Hiraki, PhD
rogel and blondy pancreatic cancer center, Michigan medicine
Slide 3
Mariana Tannus Ruckert, PhD
Rogel And Blondy pancreatic cancer center, Michigan Medicine
Slide 2
Aatur Singhi, MD, PhD
University of Pittsburgh Medical Center
Slide 6
Chris Halbrook, PhD
Chao Family Comprehensive Cancer Center
Slide 5
Asfar S. Azmi, PhD
Wayne State University & Barbara Ann Karmanos Cancer Institute
Slide 4
Arnav Mehta, MD, PhD
The Eli and Edythe L. Broad Institute of MIT and Harvard
Slide 6
Ben Z. Stanger, MD, PhD
Hanna Wise Professor of Cancer Research
Slide 6
Despoina Kalfakakou, PhD
NYU Langone Health
Slide 6
Howard Crawford, PhD
Scientific Director, Henry Ford Pancreatic Cancer Center
Slide 6
Jiao Shen
Dana-Farber Cancer Institute
Slide 6
Jurgis Alvikas, MD
University of Pittsburgh Medical Center, Department of Surgery, Division of Surgical Oncology
Slide 6
Kathleen DelGiorno MD, PhD
Vanderbilt University
Slide 6
Kirsten L. Bryant, PhD
Lindeberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Slide 6
Lisa Miller-Phillips, MD
University of California San Francisco
Slide 6
Nikki Lytle, PhD
Medical College of Wisconsin, MCW Cancer Center, LaBahn Pancreatic Cancer Program
Slide 6
Nina Steele, PhD
Henry Ford Health, Detroit, MI
Slide 6
Pamela Itkin-Ansari, PhD
Sanford-Burnham-Prebys Medical Discovery Institute, University of California, San Diego
Slide 6
Peter Wang, PhD
Massachusetts General Hospital
Slide 6
Rafael A. Fridman, PhD
Wayne State University, Karmanos Cancer Institute, Detroit
Block
Guidance, Resources, and Support for Every Step of the Journey
Facing pancreatic cancer—whether as a patient or caregiver—can feel overwhelming. At Sky Foundation, we’ve built trusted resources, tools, and a community of advocates to help you navigate the road ahead with confidence.
We continue to review the basics of clinical trials.
Learn how trials are structured, how to find and evaluate options using TriCan’s platform, what the enrollment process looks like, and how to prepare for participation with confidence.
This is the recording of the first episode in our Clinical Trials Explained: Know Your Options series, focused on pancreatic cancer clinical trials. In this session, leading experts break down how clinical trials work, how research moves from the lab to patient care, and why trials are an important part of advancing treatment options.
Recent federal budget decisions signal renewed national momentum for cancer research—including meaningful progress for pancreatic cancer. In March 2026, Congress